<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">38822168</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5489</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>May</Month><Day>31</Day></PubDate></JournalIssue><Title>International journal of impotence research</Title><ISOAbbreviation>Int J Impot Res</ISOAbbreviation></Journal><ArticleTitle>Comparing risk of post infection erectile dysfunction following SARS Coronavirus 2 stratified by acute and long COVID, hospitalization status, and vasopressor administration: a U.S. large claims database analysis.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41443-024-00913-7</ELocationID><Abstract><AbstractText>No study has yet assessed the risk of developing erectile dysfunction (ED) after a diagnosis of long COVID, defined by the Centers for Disease Control and Prevention as the persistence or presence of new symptoms at least 4 weeks after initial SARS-CoV-2 infection, when compared to those diagnosed with acute COVID or cases in which more severe treatment is required. To assess these risks, we queried the TriNetX COVID-19 Research Network from December 1st 2020 through June 2023. Men aged &#x2265; 18 diagnosed with long COVID were compared to those diagnosed with acute COVID and analyses were performed to compare men who were/were not hospitalized within 1 month of acute COVID diagnosis and men who did/did not need vasopressors. Cohorts were propensity score matched and compared for differences in new ED diagnosis and/or prescription of phosphodiesterase-5 inhibitors (PDE5i). After propensity score matching, the long and acute COVID cohorts included 2839 men with an average age of 54.5&#xb1;16.7 and 55.1&#xb1;17.1 years respectively (p&#x2009;=&#x2009;0.21). Men with long COVID were more likely to develop ED or be prescribed PDE5i (3.63%) when compared to men with only acute COVID infections (2.61%) [RR 1.39; 95% CI 1.04, 1.87]. There was no statistically significant risk of developing ED or being prescribed PDE5i for individuals who received vasopressors [RR 0.92; 95% CI 0.77,1.10] or were hospitalized [RR 0.93; 95% CI 0.82,1.06].</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grutman</LastName><ForeName>Aurora J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0001-8162-826X</Identifier><AffiliationInfo><Affiliation>The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilliam</LastName><ForeName>Kelli</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Texas Medical Branch at Galveston School of Medicine, Galveston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maremanda</LastName><ForeName>Ankith P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Able</LastName><ForeName>Corey</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Texas Medical Branch at Galveston School of Medicine, Galveston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Una</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshak</LastName><ForeName>Mark N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kohn</LastName><ForeName>Taylor P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA. tpkohn@jhmi.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Impot Res</MedlineTA><NlmUniqueID>9007383</NlmUniqueID><ISSNLinking>0955-9930</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>1</Day><Hour>10</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>1</Day><Hour>10</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>31</Day><Hour>23</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38822168</ArticleId><ArticleId IdType="doi">10.1038/s41443-024-00913-7</ArticleId><ArticleId IdType="pii">10.1038/s41443-024-00913-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Accessed June 24, 2023. https://covid19.who.int/info .</Citation></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, Havervich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383:120&#x2013;8. https://doi.org/10.1056/NEJMoa2015432 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId><ArticleId IdType="pmc">7412750</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;27. https://doi.org/10.1016/S2215-0366(21)00084-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId><ArticleId IdType="pmc">8023694</ArticleId></ArticleIdList></Reference><Reference><Citation>Florencio LL, Fern&#xe1;ndez-de-Las-Pe&#xf1;as C. Long COVID: systemic inflammation and obesity as therapeutic targets. Lancet Respir Med. 2022;10:726&#x2013;7. https://doi.org/10.1016/S2213-2600(22)00159-X .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00159-X</ArticleId><ArticleId IdType="pubmed">35472305</ArticleId><ArticleId IdType="pmc">9034853</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaynar M, Gomes ALQ, Sokolakis I, G&#xfc;l M. Tip of the iceberg: erectile dysfunction and COVID-19. Int J Impot Res. 2022;34:152&#x2013;7. https://doi.org/10.1038/s41443-022-00540-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41443-022-00540-0</ArticleId><ArticleId IdType="pubmed">35152276</ArticleId><ArticleId IdType="pmc">8853253</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheat WH, Wetsel R, Falus A, Tack BF, Strunk RC. The fifth component of complement (C5) in the mouse. Analysis of the molecular basis for deficiency. J Exp Med. 1987;165:1442&#x2013;7. https://doi.org/10.1084/jem.165.5.1442 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.165.5.1442</ArticleId><ArticleId IdType="pubmed">3572304</ArticleId></ArticleIdList></Reference><Reference><Citation>Harirugsakul K, Wainipitapong S, Phannajit J, Paitoonpong L, Tantiwongse K. Erectile dysfunction after COVID-19 recovery: a follow-up study. PLoS One. 2022;17:e0276429 https://doi.org/10.1371/journal.pone.0276429 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0276429</ArticleId><ArticleId IdType="pubmed">36264947</ArticleId><ArticleId IdType="pmc">9584530</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingery JR, Safford MM, Martin P, Lau JD, Rajan M, Wehmeyer GT, et al. Health status, persistent symptoms, and effort intolerance one year after acute COVID-19 infection. J Gen Intern Med. 2022;37:1218&#x2013;25. https://doi.org/10.1007/s11606-021-07379-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07379-z</ArticleId><ArticleId IdType="pubmed">35075531</ArticleId><ArticleId IdType="pmc">8786200</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;46. https://doi.org/10.1038/s41579-022-00846-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId><ArticleId IdType="pmc">9839201</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. Post-COVID Conditions: Information for Healthcare Providers. Published December 16, 2022. Accessed June 23, 2023. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html .</Citation></Reference><Reference><Citation>Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54&#x2013;61. https://doi.org/10.1016/s0022-5347(17)34871-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-5347(17)34871-1</ArticleId><ArticleId IdType="pubmed">8254833</ArticleId></ArticleIdList></Reference><Reference><Citation>National Center for Health Statistics. Household Pulse Survey, 2022-3. Long COVID. https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm .</Citation></Reference><Reference><Citation>Al-kuraishy HM, Al-Gareeb AI, Alarfaj SJ, Al-Akeel RJ, Faidah H, El-Bouseary MM, et al. Long COVID and risk of erectile dysfunction in recovered patients from mild to moderate COVID-19. Sci Rep. 2023;13:5977. https://doi.org/10.1038/s41598-023-32211-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-32211-5</ArticleId><ArticleId IdType="pubmed">37045862</ArticleId><ArticleId IdType="pmc">10092929</ArticleId></ArticleIdList></Reference><Reference><Citation>Labgold K, Stanhope KK, Joseph NT, Platner M, Jamieson DJ, Boulet SL. Validation of hypertensive disorders during pregnancy: ICD-10 codes in a high-burden Southeastern United States Hospital. Epidemiology. 2021;32:591&#x2013;7. https://doi.org/10.1097/EDE.0000000000001343 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000001343</ArticleId><ArticleId IdType="pubmed">34009824</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKay EJ, Salmon MK, Fatuzzo MR, Neuman MD, Desai ND, Groeneveld PW, et al. Validation of claims data for the identification of intraoperative transesophageal echocardiography during cardiac surgery. J Cardiothorac Vasc Anesthesia. 2021;35:3193&#x2013;8. https://doi.org/10.1053/j.jvca.2021.04.017 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2021.04.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H, Li B, Duncan Saunders L, Parsons GA, Nilsson CI, Alibhai A, et al. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database: assessing validity of ICD-9-CM and ICD-10. Health Serv Res. 2008;43:1424&#x2013;41. https://doi.org/10.1111/j.1475-6773.2007.00822.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1475-6773.2007.00822.x</ArticleId><ArticleId IdType="pubmed">18756617</ArticleId><ArticleId IdType="pmc">2517283</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ, Halim A, Halim M, Liu S, Aljeldah M, Al Shammari BR, et al. Inflammatory and vascular biomarkers in post-COVID-19 syndrome: a systematic review and meta-analysis of over 20 biomarkers. Rev Med Virol. 2023;33:e2424. https://doi.org/10.1002/rmv.2424 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2424</ArticleId><ArticleId IdType="pubmed">36708022</ArticleId></ArticleIdList></Reference><Reference><Citation>Taskiran M, Dogan K. The efficacy of systemic inflammatory response and oxidative stress in erectile dysfunction through multi-inflammatory index: a prospective cross-sectional analysis. J Sex Med. 2023;20:591&#x2013;6. https://doi.org/10.1093/jsxmed/qdad037 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jsxmed/qdad037</ArticleId><ArticleId IdType="pubmed">36990965</ArticleId></ArticleIdList></Reference><Reference><Citation>So M, Kabata H, Fukunaga K, Takagi H, Kuno T. Radiological and functional lung sequelae of COVID-19: a systematic review and meta-analysis. BMC Pulm Med. 2021;21:97. https://doi.org/10.1186/s12890-021-01463-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-021-01463-0</ArticleId><ArticleId IdType="pubmed">33752639</ArticleId><ArticleId IdType="pmc">7983097</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu PP, Blet A, Smyth D, Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation. 2020;142:68&#x2013;78. https://doi.org/10.1161/CIRCULATIONAHA.120.047549 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047549</ArticleId><ArticleId IdType="pubmed">32293910</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin HO, Myung SC, Kim SC, Lee MY. The effects of vasopressin and desmopressin on the contractile and relaxation responses of rabbit cavernosal smooth muscle. Korean J Urol. 2008;49:366. https://doi.org/10.4111/kju.2008.49.4.366 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4111/kju.2008.49.4.366</ArticleId></ArticleIdList></Reference><Reference><Citation>Trussell JC, Kunselman AR, Legro RS. Epinephrine is associated with both erectile dysfunction and lower urinary tract symptoms. Fertil Steril. 2010;93:837&#x2013;42. https://doi.org/10.1016/j.fertnstert.2008.10.034 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2008.10.034</ArticleId><ArticleId IdType="pubmed">19062003</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>